Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain.

Name: Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain.
Author: Johansson, Erin

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain. — المؤلف: Johansson, Erin — ClinicoEconomics and outcomes research : CEOR 2018

المؤلف: Johansson, Erin
النشر: ClinicoEconomics and outcomes research : CEOR 2018
الوصف: 747-759 p.